Skip to main content
GH logo

Guardant Health, Inc.

GHNASDAQHealthcareDiagnostics & Research

$173.25Today:- (-)1Y +134.95%

As of Oct 26, 2026 close

Market cap
$23.02B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$66.59$191.05
Volume (live)
-
Avg. volume (3M)
1.90M

Guardant Health, Inc. (GH) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Guardant Health, Inc. stock.

Analyst Consensus Rating

Investment consensus from 21 professional research analysts

Consensus Rating

Buy
Based on 21 unique analysts
(32 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$203.11
+17.24% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest GH Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Max Masucci
Roth MKM
BuyInitiates
$200.00
Kallum Titchmarsh
Morgan Stanley
BuyMaintains
$200.00
Eve Burstein
Bernstein
BuyReiterates
$210.00
Casey Woodring
JP Morgan
BuyMaintains
$195.00
Eve Burstein
Bernstein
BuyMaintains
$210.00
Kallum Titchmarsh
Morgan Stanley
BuyReiterates
$185.00 → $200.00
Michael Ryskin
BofA Securities
BuyMaintains
$195.00 → $200.00
Luke Sergott
Barclays
BuyMaintains
$200.00 → $220.00
Subbu Nambi
Guggenheim
BuyMaintains
$190.00 → $200.00
Eve Burstein
Bernstein
BuyMaintains
$210.00
Evie Koslosky
Goldman Sachs
BuyMaintains
$210.00 → $225.00
Evie Koslosky
Goldman Sachs
BuyMaintains
$210.00 → $225.00
Luke Sergott
Barclays
BuyMaintains
$200.00
William Bonello
Craig-Hallum
BuyMaintains
-
William Bonello
Craig-Hallum
BuyMaintains
-
David Westenberg
Piper Sandler
BuyMaintains
$193.00
Doug Schenkel
UBS
BuyMaintains
$175.00 → $225.00
Matt Larew
William Blair
BuyMaintains
-
Jamie Clark
Rothschild & Co Redburn
BuyInitiates
$203.00
Mark Massaro
BTIG
BuyReiterates
$195.00
Sridatri Sarkar
Zacks Equity Research
BuyInitiates Coverage
-
Mason Carrico
Stephens
BuyMaintains
$195.00
Bradley Bowers
Mizuho
BuyMaintains
$200.00
Casey Woodring
JP Morgan
BuyMaintains
$195.00
Kallum Titchmarsh
Morgan Stanley
BuyInitiates Coverage
$175.00 → $185.00
Daniel Arias
Stifel Nicolaus
BuyMaintains
$130.00 → $180.00
Kyle Mikson CFA
Canaccord Genuity
BuyMaintains
$205.00
Subbu Nambi
Guggenheim
BuyReiterates
$190.00
Daniel Brennan
TD Cowen
BuyInitiates Coverage
$200.00 → $210.00
Luke Sergott
Barclays
BuyMaintains
$150.00 → $200.00
Michael Ryskin
BofA Securities
BuyMaintains
-
Dan Leonard
RBC Capital
BuyInitiates Coverage
$185.00 → $200.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for GH?

The analyst consensus rating for GH is Buy, based on the latest ratings from 21 analysts over the last 90 days.

What is the average price target for GH?

The average 12-month price target for GH is $203.11, representing an upside of 17.2% from the Oct 26, 2026 close of $173.25.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.